Cambridge Trust’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$194K Buy
2,000
+510
+34% +$44.9K 0.01% 267
2023
Q4
$117K Hold
1,490
﹤0.01% 320
2023
Q3
$93.4K Sell
1,490
-270
-15% -$17.7K ﹤0.01% 350
2023
Q2
$113K Hold
1,760
0.01% 341
2023
Q1
$93.3K Sell
1,760
-240
-12% -$11.8K ﹤0.01% 363
2022
Q4
$84K Sell
2,000
-500
-20% -$20.9K ﹤0.01% 393
2022
Q3
$92K Buy
2,500
+150
+6% +$6.68K ﹤0.01% 372
2022
Q2
$100K Buy
2,350
+80
+4% +$3.81K ﹤0.01% 389
2022
Q1
$122K Sell
2,270
-1,160
-34% -$67.5K ﹤0.01% 396
2021
Q4
$247K Buy
+3,430
New +$215K 0.01% 307
2020
Q4
Sell
-7,180
Closed -$238K 237
2020
Q3
$238K Buy
7,180
+850
+13% +$29.3K 0.01% 209
2020
Q2
$244K Buy
+6,330
New +$173K 0.01% 217

Other funds holding LRCX

Cambridge Trust's LRCX Position: Q1 2024 in Review

Cambridge Trust increased its Lam Research (LRCX) stake by 34% in Q1 2024, buying an estimated $44.9K and bringing the position to 2,000 shares worth $194K. The position accounts for 0.01% of the portfolio, ranked #267.

Cambridge Trust first reported a position in LRCX in Q2 2020 and has held it in 12 quarters since. The position peaked at $247K in Q4 2021. 1,731 funds tracked by Wall St. Rank hold LRCX as of Q1 2024.

  • Cambridge Trust held 2,000 shares of Lam Research worth $194K as of Q1 2024.
  • Cambridge Trust bought 510 Lam Research shares in Q1 2024, an estimated $44.9K.
  • Lam Research made up 0.01% of Cambridge Trust's portfolio in Q1 2024, its #267 holding.
  • Cambridge Trust first reported a position in Lam Research in Q2 2020 and has held it in 12 quarters since.
  • Cambridge Trust's Lam Research position peaked at $247K in Q4 2021.
  • 1,731 funds tracked by Wall St. Rank held Lam Research as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.